Dolasetron
63 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
63
Total Reports
31
Deaths Reported
4920.0%
Death Rate
Active Ingredients
Dolasetron
Administration Routes
UnknownSubcutaneousOralParenteralIntravenous
Species Affected
Dog 54
Cat 9
Most Affected Breeds
Retriever - Labrador 14
Domestic Shorthair 5
Beagle 4
Spaniel (unspecified) 3
Spitz - German Pomeranian 3
Maltese 2
Terrier - Bull - American Pit 2
Retriever - Golden 2
Bichon Frise 2
Chihuahua 2
Most Reported Reactions
Vomiting 29
Other abnormal test result NOS 24
Lethargy (see also Central nervous system depression in 'Neurological') 22
Death by euthanasia 21
Elevated serum alkaline phosphatase (SAP) 21
Elevated alanine aminotransferase (ALT) 20
Anorexia 19
Abnormal ultrasound finding 18
Diarrhoea 18
Elevated total bilirubin 17
Anaemia NOS 16
Leucocytosis NOS 14
Outcome Breakdown
Ongoing
22 (34.4%)
Euthanized
20 (31.3%)
Died
11 (17.2%)
Recovered/Normal
8 (12.5%)
Outcome Unknown
3 (4.7%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.